146 related articles for article (PubMed ID: 20112328)
1. Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system.
Gattinoni S; De Simone C; Dallavalle S; Fezza F; Nannei R; Amadio D; Minetti P; Quattrociocchi G; Caprioli A; Borsini F; Cabri W; Penco S; Merlini L; Maccarrone M
ChemMedChem; 2010 Mar; 5(3):357-60. PubMed ID: 20112328
[No Abstract] [Full Text] [Related]
2. A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.
Gattinoni S; Simone CD; Dallavalle S; Fezza F; Nannei R; Battista N; Minetti P; Quattrociocchi G; Caprioli A; Borsini F; Cabri W; Penco S; Merlini L; Maccarrone M
Bioorg Med Chem Lett; 2010 Aug; 20(15):4406-11. PubMed ID: 20591666
[TBL] [Abstract][Full Text] [Related]
3. Oxime carbamate--discovery of a series of novel FAAH inhibitors.
Sit SY; Conway CM; Xie K; Bertekap R; Bourin C; Burris KD
Bioorg Med Chem Lett; 2010 Feb; 20(3):1272-7. PubMed ID: 20036536
[TBL] [Abstract][Full Text] [Related]
4. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
[TBL] [Abstract][Full Text] [Related]
6. 3-Heterocycle-phenyl N-alkylcarbamates as FAAH inhibitors: design, synthesis and 3D-QSAR studies.
Käsnänen H; Myllymäki MJ; Minkkilä A; Kataja AO; Saario SM; Nevalainen T; Koskinen AM; Poso A
ChemMedChem; 2010 Feb; 5(2):213-31. PubMed ID: 20024981
[TBL] [Abstract][Full Text] [Related]
7. Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.
Myllymäki MJ; Käsnänen H; Kataja AO; Lahtela-Kakkonen M; Saario SM; Poso A; Koskinen AM
Eur J Med Chem; 2009 Oct; 44(10):4179-91. PubMed ID: 19539407
[TBL] [Abstract][Full Text] [Related]
8. Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling.
Lodola A; Capoferri L; Rivara S; Chudyk E; Sirirak J; Dyguda-Kazimierowicz E; Andrzej Sokalski W; Mileni M; Tarzia G; Piomelli D; Mor M; Mulholland AJ
Chem Commun (Camb); 2011 Mar; 47(9):2517-9. PubMed ID: 21240393
[TBL] [Abstract][Full Text] [Related]
9. Design of on-target FAAH inhibitors.
Deutsch DG
Chem Biol; 2005 Nov; 12(11):1157-8. PubMed ID: 16298293
[TBL] [Abstract][Full Text] [Related]
10. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
Morera E; De Petrocellis L; Morera L; Moriello AS; Ligresti A; Nalli M; Woodward DF; Di Marzo V; Ortar G
Bioorg Med Chem Lett; 2009 Dec; 19(23):6806-9. PubMed ID: 19875281
[TBL] [Abstract][Full Text] [Related]
13. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
[TBL] [Abstract][Full Text] [Related]
14. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
[TBL] [Abstract][Full Text] [Related]
15. The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.
Minkkilä A; Myllymäki MJ; Saario SM; Castillo-Melendez JA; Koskinen AM; Fowler CJ; Leppänen J; Nevalainen T
Eur J Med Chem; 2009 Jul; 44(7):2994-3008. PubMed ID: 19232787
[TBL] [Abstract][Full Text] [Related]
16. O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors.
Niphakis MJ; Johnson DS; Ballard TE; Stiff C; Cravatt BF
ACS Chem Neurosci; 2012 May; 3(5):418-26. PubMed ID: 22860211
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes.
Alexander JP; Cravatt BF
Chem Biol; 2005 Nov; 12(11):1179-87. PubMed ID: 16298297
[TBL] [Abstract][Full Text] [Related]
18. Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice.
Yesilyurt O; Cayirli M; Sakin YS; Seyrek M; Akar A; Dogrul A
Arch Dermatol Res; 2016 Jul; 308(5):335-45. PubMed ID: 27126057
[TBL] [Abstract][Full Text] [Related]
19. ω-Imidazolyl- and ω-Tetrazolylalkylcarbamates as Inhibitors of Fatty Acid Amide Hydrolase: Biological Activity and in vitro Metabolic Stability.
Terwege T; Hanekamp W; Garzinsky D; König S; Koch O; Lehr M
ChemMedChem; 2016 Feb; 11(4):429-43. PubMed ID: 26732805
[TBL] [Abstract][Full Text] [Related]
20. Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol.
Soukupová M; Palazzo E; De Chiaro M; Gatta L; Migliozzi AL; Guida F; Luongo L; Giordano C; Siniscalco D; De Novellis V; Marabese I; Krsiak M; Maione S
Neuro Endocrinol Lett; 2010; 31(4):507-11. PubMed ID: 20802454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]